Page last updated: 2024-12-07

4-methylumbelliferyl-beta-d-mannoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-Methylumbelliferyl-beta-D-mannoside (MUF-Man) is a fluorogenic substrate for mannosidases. It is a synthetic compound that is widely used in research to study the activity of these enzymes. The compound consists of a mannose sugar molecule linked to a 4-methylumbelliferyl (MUF) fluorophore. When the mannosidase enzyme hydrolyzes the mannose from the MUF-Man, the MUF fluorophore is released and becomes fluorescent. This fluorescence can be measured, allowing researchers to determine the activity of the mannosidase enzyme. MUF-Man is often used in assays to screen for inhibitors of mannosidases, which are enzymes that play a role in various biological processes, including the degradation of glycoproteins and the synthesis of oligosaccharides. The compound is also used to study the role of mannosidases in diseases, such as cancer and lysosomal storage disorders. MUF-Man is a valuable tool for studying mannosidases and their role in biological processes. It is a synthetic compound that is easy to use and can be reliably measured. This has made it a popular choice for researchers studying these enzymes.'

4-methylumbelliferyl-beta-D-mannopyranoside: see also record for (alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID119835
SCHEMBL ID2319034
MeSH IDM0052425

Synonyms (50)

Synonym
4-methyl-2-oxo-2h-chromen-7-yl hexopyranoside
7-(alpha-d-galactopyranosyloxy)-4-methyl-2h-1-benzopyran-2-one
einecs 254-031-1
66901-41-5
OPREA1_865930
TIMTEC1_001369
4-methylumbelliferyl-alpha-d-galactopyranoside
NCGC00174504-01
4-methylumbelliferyl-beta-d-mannopyranoside
HMS1537O05
ZINC00519404
BRD-A18403956-001-01-5
4-methyl-2-oxo-2h-1-benzopyran-7-yl |a-d-glucopyranosiduronic acid
4-methyl-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
4-methyl-7-[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
A833330
4-methyl-7-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-2h-chromen-2-one
4-methylumbelliferyl-beta-d-glucoside
7-(alpha-d-mannopyranosyloxy)-4-methyl-2h-1-benzopyran-2-one
para-methylumbelliferyl-alpha-d-mannopyranoside
4-methylumbelliferylmannoside
methylumbelliferyl-alpha-d-mannopyranoside
einecs 249-073-2
4-methylumbelliferyl-beta-d-mannoside
4-methyl-7-[3,4,5-trihydroxy-6-(hydroxymethyl)(2h-3,4,5,6-tetrahydropyran-2-yl oxy)]chromen-2-one
FT-0672337
4-methylumbelliferyl a-l-idopyranoside
FT-0619135
FT-0619136
FT-0619143
FT-0619134
FT-0619120
FT-0619144
SCHEMBL2319034
AKOS024275780
HMS3604E20
mu-alpha-gal
STL510783
YUDPTGPSBJVHCN-UHFFFAOYSA-N
BCP33856
4-mu-glu; 4-mu-(c)micro-gluc;4-methylumbelliferyl glucoside;4-methylumbelliferyl beta-d-glucoside
4-methylumbelliferyl (c)micro-d-glucopyranoside
4-mu-beta-d-glc
4-methylumbelliferyl- beta -d-glucopyranoside
SB48435
SB48378
SB48482
4-methylumbelliferyl alpha -l-idopyranoside
4-methylumbelliferyla-l-idopyranoside
PD042362
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (58.82)18.7374
1990's3 (17.65)18.2507
2000's2 (11.76)29.6817
2010's2 (11.76)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.28 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]